Dr. Eugene Hwang, MD
Claim this profileChildren's National Medical Center
Expert in Brain Tumor
Studies Diffuse Intrinsic Pontine Glioma
18 reported clinical trials
30 drugs studied
About Eugene Hwang, MD
Education:
- Obtained MD from the University of California, San Francisco School of Medicine in 2006.
- Completed Residency in Pediatrics at Children's National Medical Center in 2009.
- Finished Fellowship in Pediatric Infectious Diseases at Children's National Medical Center in 2012.
Experience:
- Associate Professor of Pediatrics and Director of the Division of Pediatric Infectious Diseases at Children's National Medical Center.
Area of expertise
1Brain Tumor
Global LeaderStage IV
NTRK positive
Stage III
2Diffuse Intrinsic Pontine Glioma
NTRK positive
IDH positive
Stage IV
Affiliated Hospitals
Clinical Trials Eugene Hwang, MD is currently running
PEP-CMV Vaccine
for Pediatric Brain Tumor
This study will address the question of whether targeting CMV antigens with PEP-CMV can serve as a novel immunotherapeutic approach in pediatric patients with newly-diagnosed high-grade glioma (HGG) or diffuse intrinsic pontine glioma (DIPG) as well as recurrent medulloblastoma (MB). PEP-CMV is a vaccine mixture of a peptide referred to as Component A. Component A is a synthetic long peptide (SLP) of 26 amino acid residues from human pp65. The SLPs encode multiple potential class I, class II, and antibody epitopes across several haplotypes. Component A will be administered as a stable water:oil emulsion in Montanide ISA 51. Funding Source - FDA OOPD
Recruiting1 award Phase 2
Savolitinib
for Brain Tumors
This phase I trial studies the side effects and best dose of volitinib in treating patients with primary central nervous system (CNS) tumors that have come back (recurrent) or does not respond to treatment (refractory). Volitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Recruiting1 award Phase 1
More about Eugene Hwang, MD
Clinical Trial Related1 year of experience running clinical trials · Led 18 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Eugene Hwang, MD has experience with
- Vismodegib
- Cyclophosphamide
- Cisplatin
- Vincristine
- Craniospinal Irradiation With Boost To The Primary Tumor Site
- INCB7839
Breakdown of trials Eugene Hwang, MD has run
Brain Tumor
Diffuse Intrinsic Pontine Glioma
Glioblastoma
Medulloblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eugene Hwang, MD specialize in?
Eugene Hwang, MD focuses on Brain Tumor and Diffuse Intrinsic Pontine Glioma. In particular, much of their work with Brain Tumor has involved Stage IV patients, or patients who are NTRK positive.
Is Eugene Hwang, MD currently recruiting for clinical trials?
Yes, Eugene Hwang, MD is currently recruiting for 7 clinical trials in Washington District of Columbia. If you're interested in participating, you should apply.
Are there any treatments that Eugene Hwang, MD has studied deeply?
Yes, Eugene Hwang, MD has studied treatments such as Vismodegib, Cyclophosphamide, Cisplatin.
What is the best way to schedule an appointment with Eugene Hwang, MD?
Apply for one of the trials that Eugene Hwang, MD is conducting.
What is the office address of Eugene Hwang, MD?
The office of Eugene Hwang, MD is located at: Children's National Medical Center, Washington, District of Columbia 20010 United States. This is the address for their practice at the Children's National Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.